Clinical Trial Update: Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 Injection [EARLY_Phase 1]

View source ↗

Summary

An exploratory early-phase study evaluating WGb-0302 injections for recurrent and refractory hematologic malignancies. The trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• WGb-0302

Snippet

Sponsor: Sichuan University | Conditions: Hematological Malignancies | EARLY_Phase 1 | Status: NOT_YET_RECRUITING